Artificial blood vessel: the Holy Grail of peripheral vascular surgery
- PMID: 15768021
- DOI: 10.1016/j.jvs.2004.12.026
Artificial blood vessel: the Holy Grail of peripheral vascular surgery
Abstract
Artificial blood vessels composed of viable tissue represent the ideal vascular graft. Compliance, lack of thrombogenicity, and resistance to infections as well as the ability to heal, remodel, contract, and secrete normal blood vessel products are theoretical advantages of such grafts. Three basic elements are generally required for the construction of an artificial vessel: a structural scaffold, made either of collagen or a biodegradable polymer; vascular cells, and a nurturing environment. Mechanical properties of the artificial vessels are enhanced by bioreactors that mimic the in vivo environment of the vascular cells by producing pulsatile flow. Alternative approaches include the production of fibrocollagenous tubes within the recipient's own body (subcutaneous tissue or peritoneal cavity) and the construction of an artificial vessel from acellular native tissues, such as decellularized small intestine submucosa, ureter, and allogeneic or xenogeneic arteries. This review details the most recent developments on vascular tissue engineering, summarizes the results of initial experiments on animals and humans, and outlines the current status and the challenges for the future.
Similar articles
-
Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.Ann Plast Surg. 2009 Mar;62(3):297-303. doi: 10.1097/SAP.0b013e318197eb19. Ann Plast Surg. 2009. PMID: 19240529
-
Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors.Biomaterials. 2007 Feb;28(6):1115-22. doi: 10.1016/j.biomaterials.2006.10.025. Epub 2006 Nov 16. Biomaterials. 2007. PMID: 17112581
-
Tissue-engineered blood vessels: alternative to autologous grafts?Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1128-34. doi: 10.1161/01.ATV.0000158996.03867.72. Epub 2005 Feb 10. Arterioscler Thromb Vasc Biol. 2005. PMID: 15705929 Review.
-
Decellularized vein as a potential scaffold for vascular tissue engineering.J Vasc Surg. 2004 Jul;40(1):146-53. doi: 10.1016/j.jvs.2004.03.033. J Vasc Surg. 2004. PMID: 15218475
-
Developments towards tissue-engineered, small-diameter arterial substitutes.Expert Rev Med Devices. 2008 May;5(3):337-47. doi: 10.1586/17434440.5.3.337. Expert Rev Med Devices. 2008. PMID: 18452384 Review.
Cited by
-
Shear- vs. nanotopography-guided control of growth of endothelial cells on RGD-nanoparticle-nanowell arrays.J Biol Eng. 2013 Apr 22;7(1):11. doi: 10.1186/1754-1611-7-11. J Biol Eng. 2013. PMID: 23607894 Free PMC article.
-
Optimum parameters for freeze-drying decellularized arterial scaffolds.Tissue Eng Part C Methods. 2013 Dec;19(12):981-90. doi: 10.1089/ten.TEC.2012.0741. Epub 2013 Jun 25. Tissue Eng Part C Methods. 2013. PMID: 23614758 Free PMC article.
-
Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.Acta Biomater. 2019 Aug;94:183-194. doi: 10.1016/j.actbio.2019.05.063. Epub 2019 Jun 12. Acta Biomater. 2019. PMID: 31200116 Free PMC article.
-
The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues.J Vasc Surg. 2011 Nov;54(5):1451-60. doi: 10.1016/j.jvs.2011.05.050. Epub 2011 Aug 27. J Vasc Surg. 2011. PMID: 21872418 Free PMC article.
-
Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts.Tissue Eng Part B Rev. 2013 Aug;19(4):292-307. doi: 10.1089/ten.TEB.2012.0577. Epub 2013 Feb 13. Tissue Eng Part B Rev. 2013. PMID: 23252992 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources